Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,542 total articles
Lumentum has shifted from a niche photonics supplier into a core AI-data-center supplier. With Q3 revenue momentum, heavy buying interest from hyperscalers, and a clean product roadmap, LITE is my preferred pure-play on optical interconnects versus peers. This trade targets a mid-term run to $1,150 with a $840 stop—size accordingly given a richly p…
Keyera's midstream franchise still looks attractive after a pullback. Cheapening valuation and steady fee-based cash flow create a favorable asymmetric trade: enter at $47.50, protect at $42.00, and target $55.00 over a mid-term 45 trading day horizon.
Powell Industries (POWL) looks richly valued today at roughly $9.9B market cap and a P/E near 53, but a $1.6B backlog, double-digit order growth and near-net-cash balance sheet reduce execution risk. For disciplined traders I see a mid-term (45 trading days) long setup with a clear entry, stop and target that balances upside from backlog conversion…
Autohome (ATHM) faces revenue pressure from China’s car price wars, but a strong balance sheet, an attractive dividend yield (~10.3%), and a sub-1.0 PB multiple make the stock a tactical long for investors willing to accept execution risk. We lay out a mid-term swing plan with clear entry, target and stop-loss levels and a list of catalysts and ris…
Uber is trading at $73.70 with a $149.9B market cap and a free cash flow run-rate north of $9.1B. The company is uniquely positioned to monetize autonomy, delivery and logistics as an integrated platform. This trade targets the re-rating that comes from meaningful autonomous deployments, margin expansion and AI-driven efficiency gains.
NMI Holdings (NMIH) trades at a low-teens return on equity and single-digit P/E with a strong capital position and rising book value. Even if near-term earnings have peaked, the stock offers asymmetric upside from multiple expansion and continued book-value growth. Enter a disciplined long with a clear stop and target over a multi-month horizon.
USPH reported record Q1 revenue and reiterated full-year adjusted EBITDA guidance while absorbing non-cash accounting noise that hurt reported net income. The combination of $66.7M in free cash flow, a low-leverage balance sheet and an enlarged $450M credit facility argues the business is fundamentally intact. The market has largely priced the name…
Morgan Stanley ($200.44) has re-accelerated after a Buy upgrade and a stronger Q1 print. The bank trades at roughly 18x earnings with $14.8B in free cash flow and a $316B market cap. For traders, a mid-term swing entry around current levels offers a favorable risk/reward into catalysts including underwriting fees, buybacks and potential Fed easing.…
Chord Energy (CHRD) is trading at an attractive valuation relative to its cash generation and balance sheet strength. At a market cap near $8.04B and enterprise value of $9.30B, the stock offers a ~6.2% implied free cash flow yield and a 3.8% dividend yield. Operational scale in the Bakken, a recent strategic investment in PetroX Boost, and low deb…
AeroVironment is squarely in the crosshairs of rising defense spending and demand for counter-drone technology. With a $8.14B market cap, improving program wins (including a shipboard laser demo) and favorable technicals around oversold territory, AVAV looks like a tactical long from $165 with a $305 target and a $150 stop. The idea carries materia…
Vipshop (VIPS) beat expectations in its latest quarter, and while urban Chinese consumption is uncertain, the stock trades at a low PE (7.2) with a $0.60 annual distribution and a near-term technical setup that favors buyers. This trade plan targets a material re-rating toward historical mid-teens multiples while limiting downside at the 52-week lo…
Compass is a technology-enabled real estate platform that looks inexpensive on EV/sales and has tangible merger synergies after the Anywhere combination. This trade idea lays out a specific entry at $8.50, a protective stop at $6.50, and two pragmatic upside targets at $12.00 (mid-term) and $16.00 (long-term), with a plan tied to a housing-market r…
Roblox's recent reset after mandatory age-verification costs has materially compressed the stock. That pullback creates an actionable swing trade: buy near $46 to capture upside from 18+ cohort monetization and improving technical momentum, with a clear stop under the recent low. The idea leans on elevated ARPU potential, solid free cash flow, cons…
American Coastal Insurance (ACIC) trades at a single‑digit P/E with EV/EBITDA near 3x, a recent underwriting leadership move, and a special dividend that underscores cash generation. Technicals are neutral-to-firm and downside is definable. We upgrade to a buy and lay out an actionable entry, stop and targets for a mid‑term swing trade (45 trading …
Farmers & Merchants Bancorp (FMCB) checks a lot of boxes for conservative income-plus-growth investors: record 2025 net income, industry-leading dividend streaks, and an enlarged $57.6M repurchase authorization. At $1349.99 the shares trade at roughly a 10x P/E on recent EPS and offer a modest ~1.6% yield. Technicals show strength but near-term mom…
Microsoft's core franchises continue to generate cash and margin expansion potential while valuation sits at a reasonable multiple for quality growth. This trade idea lays out an actionable long with entry, stop and target, a catalyst list, and balanced risk discussion.
DexCom's shares are trading near $72 after a solid Q1 print, margin guidance and a fresh $1 billion buyback. The business is cash-generative, profitable and still growing: revenue was $1.2B in the most recent quarter (up ~15% YoY), adjusted gross-profit margin targets sit at 67-69% and cash on the balance sheet is roughly $2.4B. At ~29-30x reported…
Vermilion Energy (VET) has the makings of a classic re-rating setup: improving cash returns to investors, asset sales that reduce leverage and a market cap below $2 billion that still trades well under what a sustainably higher multiple could justify. This trade idea lays out a clear entry at $12.30, a stop at $10.50 and a target of $15.00 over a l…
Nvidia's blowout quarter (Q1 FY2027) and aggressive capital return make new all-time highs very likely. This trade idea lays out a specific long entry at $220.12, a protective stop at $195.00, and a primary target of $320.00, with timeline and risk management across short, mid and long horizons.
Ironwood offers an asymmetric risk-reward right now. The shares trade near $3.85 with a market cap ~ $640M, EV/EBITDA under 5 and free cash flow of $112M. Recent guidance from management for materially higher LINZESS U.S. net sales and a paradoxical list-price move that improved net pricing reset the narrative in January 2026. Meanwhile short inter…
Nvidia reported $81.6B in revenue and $75.2B in Data Center sales, added an $80B buyback authorization, and still traded off after the print. The numbers point to durable, hyperscaler-led demand for AI compute. This trade idea lays out a long entry at $220.12, a $260 target and a $200 stop, with a 180 trading-day horizon and medium risk sizing.
Applied Digital just announced a 15-year, $7.5B lease for 300 MW at Polaris Forge 3, taking its disclosed contracted lease revenue to roughly $31B and total contracted capacity to ~1GW. The market is rewarding scale; this trade idea buys a measured pullback to ride continued hyperscaler demand while respecting execution and valuation risks.
AeroVironment (AVAV) is trading well below its prior highs despite clear product demonstrations and pipeline wins. With a market cap near $8.1B, improving contract flow, and visible technology momentum in directed energy and AI-enabled perception, the risk/reward into the next earnings release looks favorable. This trade plan outlines a mid-term lo…
CRISPR Therapeutics ($CRSP) is priced like a growth story with a $4.8B market cap while the market waits on several clinical readouts and label expansion that could re-rate the shares. This trade idea lays out a long bias with an entry at $49.90, a stop at $40.00 and a $85.00 target tied to positive Phase 2/Phase 1 data and commercial progress.
Rolls-Royce (RYCEY) looks like a constructive long setup: core aerospace and aftermarket profitability remains solid, the company sits squarely in the early winners' circle for small modular reactors (SMRs) after fresh UK funding, and the stock has pulled back on sentiment rather than fundamentals. This trade targets a recovery toward the 52-week h…
